Navigation Links
Tolerx Announces Achievement of Milestones upon anti-CD4 Antibody Program Advancement and Initiation of Phase 1 Clinical Trial
Date:8/5/2008

aterially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. Factors and risks that may affect the forward-looking statements include the results of this and future clinical studies, the ability to obtain regulatory approvals for MTRX1011A, the introduction and impact of competing therapies by other companies and the dependence of Tolerx upon Genentech for further development of MTRX1011A. These statements reflect the view of Tolerx as of the date of this press release, and Tolerx undertakes no obligation to update or revise any forward- looking statements to reflect events or circumstances after the date of this press release.


'/>"/>
SOURCE Tolerx, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Tolerx Advancing Novel Type 1 Diabetes Agent into Phase III Clinical Trial Program Following End of Phase II FDA Meeting
2. Tolerx Achieves Milestone with Completion of Phase Ib Clinical Study of TRX1 in Cutaneous Lupus Erythematosus
3. Medarex Announces Allowance of Investigational New Drug Application for Wholly-Owned Fully Human Anti-PD-L1 Antibody, MDX-1105
4. Cara Therapeutics Announces Successful Completion of Phase I Clinical Trial of Novel Analgesic, CR845
5. MicroDose Technologies Announces Achievement of Phase I Clinical Milestone Triggering First Milestone Payment Under Collaboration with Merck & Co., Inc.
6. Emisphere Announces Recruitment of Novartis Phase III Study for Oral Osteoporosis Treatment
7. Amicus Therapeutics Announces Successful Completion of End of Phase 2 Meeting With FDA for Amigal in Fabry Disease
8. Anpath Group, Inc. Announces Approval of its Disinfectant by the State of Florida
9. Peptimmune Announces Grant of United States Patent for PI-2301 Peptide Copolymer for Multiple Sclerosis
10. Nile Therapeutics Announces Dosing in Second Phase Ib Study of CD-NP in Heart Failure Patients
11. Wound Management Technologies, Inc. Announces Agreement for Evidence Based Study for Diabetic Venous Ulcers

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...., Nov. 20 The Departme...hots to members of priority groups that did not ha...f 18 clinics are being held statewide on Nov. 20-2... Hours on Saturday, Nov. 21, will be 8 a.m. to 2 p...rom 2 p.m. to 8 p.m. ,, Individuals in the rec...
(Date:11/20/2009)...ov. 20 ,, Reportlinker.com anno...le in its catalogue. ,, Global Markets for Bre...linker.com/p0164741/Global-Markets-for-Breast-Biop..._medium=pr&utm_campaign=prnewswire ,, The... the spring loaded core needle market and vacuum a...
(Date:11/20/2009)... 20 Cyberonics, Inc. (Na...ident and Chief Executive Officer, and Greg Browne...t Annual Piper Jaffray Health Care Conference in N... EST. The conference session and webcast will be ... Piper Jaffray will host a webcast of the present...
Breaking Medicine Technology:Pennsylvania Department of Health Begins Statewide H1N1 Vaccination Clinics Targeting Priority Populations; Some Appointments Still Available 2Reportlinker Adds Global Markets for Breast Biopsy Devices 2009 2Cyberonics to Present at 21st Annual Piper Jaffray Health Care Conference 2Press Ganey Announces Opening of Boston Office 50837 1Press Ganey Announces Opening of Boston Office 50837 2Cancer Roadmaps Chooses Tableau Software for Consumer Access to Online Interactive Dashboards for Cancer Patients 50834 1Cancer Roadmaps Chooses Tableau Software for Consumer Access to Online Interactive Dashboards for Cancer Patients 50834 2Cancer Roadmaps Chooses Tableau Software for Consumer Access to Online Interactive Dashboards for Cancer Patients 50834 3Nitrogen research shows how some plants invade take over others 9126 1Nitrogen research shows how some plants invade take over others 9126 2
...icromet, Inc.,(Nasdaq: MITI ), a biopharmaceutic...s for the treatment of cancer, inflammation and au...s anticipated for the year 2009. , Micromet in...elopment,programs at the following events: , -...cal BiTE antibodies at,the American Association fo...
...3 Warner Chilcott Limited (Nasdaq: WCRX ) annou...Pharma International Pty. Ltd. ("Mayne"), a subsid... each of Mutual Pharmaceutical Company, Inc. ("Mut...pax Laboratories, Inc. ("Impax") in the District ...ent of Mayne,s U.S. Patent No. 6,958,161 (the ",16...
Other Medicine Technology:Micromet Key Events for 2009 2Micromet Key Events for 2009 3Micromet Key Events for 2009 4Micromet Key Events for 2009 5Warner Chilcott Files Lawsuits for Infringement of DORYX(R) Patent 2Warner Chilcott Files Lawsuits for Infringement of DORYX(R) Patent 3
(Date:11/20/2009)...ologist Closer to Understanding Brain Wiring and D...wswire/ -- Dr. Jeremy Schmahmann, Professor of Neu...t the Massachusetts General Hospital in Boston, on... research on the new field of study called "Connec...,, Dr. Schmahmann is an award-winning leader in...
(Date:11/20/2009)...ov. 20 The American Ac... health care reform legislation released this week...nsurance individual coverage mandate. The actuarie...ill minimize adverse selection stemming from more ...he bill. ,, "The individual mandate language sh...
(Date:11/20/2009)...Nov. 20 Following a recall by Unil...ed from sale Shedd,s Country Crock ® Side Dis...ry Crock ® Side Dishes DELUXE Four Cheese Pas...he following code dates and UPCs are affected: ,...E Cheddar Broccoli Rice 21 oz, UPC 027400218316, B...
(Date:11/20/2009)...., Nov. 20 Rates of infe...aked in late October, but the pandemic flu virus c...l age groups, including the elderly, according to ...SE: DGX ), the world,s leading provider of diagn... its most recent Quest Diagnostics Health Trends(T...
(Date:11/20/2009)...ov. 20 Centene Corpora...resent at the Bank of America Merrill Lynch 2009 C...t the Crowne Plaza Hotel Times Square in New York ...er 2nd at 8:30 a.m. Eastern Time. Investors and ot...bcast of Centene,s presentation at: http://www.ve...
Breaking Medicine News(10 mins):Health News:MINDlink Foundation Launches to Connect the Cerebellum to Cures 2Health News:Actuaries to Senate: Strengthen Individual Mandate 2Health News:Stop & Shop Alerts Customers to Voluntary Recall by Unilever 2Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 2Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 3
...llution than motorcycles, according to the results... for Materials Testing and Research’s Martin Weile...which revealed that the hydrocarbons emission of m...d by motorcycles were also disproportionately high...
...an increase in the number of cases reported with r...h disease // . The Department of Primary Indu...the property in Wentworth and found that the cause...of New South Wales said that than are more than 70...
... passed by the Food and Drug Administration (FDA) ...in the food // had to be mentioned in the label of...e under common food allergens are milk, eggs, fish...f death in US. The list of ingredients accounted t...
...ted by researchers from the Georgetown University ... had received their much-deserved respect. An exam... forms demonstrated that dwarfism was not consider...in many households. The hot, dry climate and sophi...
... expected to be conducted in China for the first t...l concerned had suffered extensive burn injuries /...her own aunt who used vitriol liquor in an act of ...jing Military Command’s research team led by Hong ...
...tion (FDA) has imposed strict and new guidelines t...t in candies. Lead is a very high toxic // metal w...ill effects of these lead the FDA as imposed that ...children’s and is safe for children’s to have thes...
Other Medicine News:Health News:Respecting Dwarfs- A Lesson To Be Learnt From Ancient Egyptians 2
Jet Wire Twister
Osteophyte Periosteal Elevator
Large Bone Curettes
Maltz Rasp
Medicine Products: